Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Operating Expenses (2021 - 2025)

Historic Operating Expenses for Cardio Diagnostics Holdings (CDIO) over the last 5 years, with Q3 2025 value amounting to $1.7 million.

  • Cardio Diagnostics Holdings' Operating Expenses rose 2111.59% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 2223.91%. This contributed to the annual value of $8.4 million for FY2024, which is 1572.06% up from last year.
  • Latest data reveals that Cardio Diagnostics Holdings reported Operating Expenses of $1.7 million as of Q3 2025, which was up 2111.59% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Operating Expenses ranged from a high of $4.2 million in Q1 2024 and a low of $397.0 during Q2 2021
  • In the last 5 years, Cardio Diagnostics Holdings' Operating Expenses had a median value of $1.5 million in 2023 and averaged $1.4 million.
  • As far as peak fluctuations go, Cardio Diagnostics Holdings' Operating Expenses skyrocketed by 19812770.78% in 2022, and later tumbled by 6091.26% in 2025.
  • Quarter analysis of 5 years shows Cardio Diagnostics Holdings' Operating Expenses stood at $20887.0 in 2021, then soared by 11289.89% to $2.4 million in 2022, then crashed by 34.96% to $1.5 million in 2023, then decreased by 1.71% to $1.5 million in 2024, then grew by 12.73% to $1.7 million in 2025.
  • Its Operating Expenses stands at $1.7 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.6 million for Q1 2025.